Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-10-055752
Filing Date
2010-03-15
Accepted
2010-03-12 19:50:27
Documents
10
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR THE FISCAL YEAR ENDED DECEMBER 31, 2009 d10k.htm 10-K 1586514
2 SECOND AMENDMENT TO THE EXCLUSIVE LICENSE AND COLLABORATION AGREEMENT dex1074.htm EX-10.74 36768
3 COMMERCIAL MANUFACTURING AGREEMENT dex1075.htm EX-10.75 504425
4 LIST OF SUBSIDIARIES dex211.htm EX-21.1 798
5 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 1968
6 CERTIFICATION REQUIRED BY RULE 13A-14(A) OR RULE 15D-14(A) dex311.htm EX-31.1 7565
7 CERTIFICATION REQUIRED BY RULE 13A-14(A) OR RULE 15D-14(A) dex312.htm EX-31.2 7785
8 CERTIFICATION REQUIRED BY RULE 13A-14(B) OR RULE 15D-14(B) dex321.htm EX-32.1 5155
9 GRAPHIC g78243ex10_75pg028.jpg GRAPHIC 7235
10 GRAPHIC g78243g05m52.jpg GRAPHIC 44225
  Complete submission text file 0001193125-10-055752.txt   2223677
Mailing Address 3280 BAYSHORE BLVD BRISBANE CA 94005
Business Address 3280 BAYSHORE BLVD BRISBANE CA 94005 415 466 2200
INTERMUNE INC (Filer) CIK: 0001087432 (see all company filings)

EIN.: 943296648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-29801 | Film No.: 10679404
SIC: 2834 Pharmaceutical Preparations